EGFR and central nervous system cancer: Importantly, cisplatin, as well as other DNA-targeting anti-cancer drugs including camptothecin and doxorubicin, was shown to induce EGFR tyrosine phosphorylation, and its blockage with the EGFR TKI AG1478 enhanced cisplatin-induced cell death in human glioma cells14.